|Dr. Alexandra Andrews||Chief Operating Officer||331.03k||N/A||N/A|
|Prof. Allan Cripps A.O., AO, B.Sc., Ph.D.||Chief Scientist & Innovation and Director||40k||N/A||N/A|
|Dr. Emanuela Russo||Chief Scientific Officer & Member of Scientific Advisory Board||N/A||N/A||N/A|
|Mr. Gerald Quigley||Director of PR & Director||N/A||N/A||N/A|
|Dr. Thomas Duthy M.B.A., Ph.D.||Exec. Director||N/A||N/A||N/A|
|Mr. Peter James Lawrence Griffiths B.Sc.||Chief Exec. Officer of AAT Research Ltd||N/A||N/A||1964|
|Ms. Erlyn Saromines Dawson A.C.I.S., ACIS, AGIA, B.Com., BCom., GradDipACG||Company Sec.||N/A||N/A||N/A|
Neurotech International Limited, together with its subsidiaries, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is focused on development and commercializing Mente platform, a platform technology to monitor and play role in home-based therapies. Its product includes Mente Autism for the diagnosis and treatment of autism. It also engages in executing of medical research projects; and developing of technological devices. The company was incorporated in 2016 and is based in Nedlands, Australia.
Neurotech International Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.